Clinical trials sponsored by Grupo Español Multidisciplinar de Melanoma

Phase breakdown

Conditions studied

Recruiting trials led by Grupo Español Multidisciplinar de Melanoma

• Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
  NCT03605771 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 39 locations
• Encorafenib and biNimetinib Followed by CEmiplimab and FiAnLimab in Patients With BRAF Mutant melanOma and Symptomatic Brain Metastases
  NCT06887088 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 18 locations
• Neoadjuvant Tebentafusp in Patients With Metastatic Uveal Melanoma
  NCT07057596 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients
  NCT06906822 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 13 locations

Common questions

How many trials is Grupo Español Multidisciplinar de Melanoma recruiting for?

Grupo Español Multidisciplinar de Melanoma is the lead sponsor of 4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.